SCIENCE WITHOUT BORDERS. MADE FOR THE MIDDLE EAST.FOR LABORATORY RESEARCH ONLYA CONSIDERED APPROACH TO RESEARCH
THE SILSILA RESEARCH COLLECTION

Repair research

Explore thoughtfully selected formats for laboratory research.

LL-37 5mg — illustrative product packagingLL-37 5MGPeptide pens
OMR 44.00 · $114

LL-37 is a natural, 37-amino-acid antimicrobial peptide. Found in immune and barrier tissues, it is studied for microbial defence and immune-cell signalling.

Regen Ultra — illustrative product packagingREGEN ULTRAPeptide pens
OMR 64.50 · $168

BPC-157, TB-500 and KPV combined in one formulation. Separate studies investigate tissue repair and inflammatory pathways; the combination’s effects are not established.

KPV 20mg — illustrative product packagingKPV 20MGPeptide pens
OMR 49.30 · $128

KPV is a three-amino-acid fragment of alpha-MSH. Laboratory and animal studies explore how this small peptide interacts with inflammatory pathways, including gut-related models.

TB-500 20mg — illustrative product packagingTB-500 20MGPeptide pens
OMR 54.00 · $140

TB-500 is associated with a fragment of thymosin beta-4. Research examines peptide identity and tissue-related signalling; full-length thymosin findings cannot be assumed for this fragment.

Regen 20 — illustrative product packagingREGEN 20Peptide pens
OMR 49.30 · $128

Regen 20 pairs BPC-157 with TB-500. Ingredient research explores tissue-related pathways, largely in experimental settings; combined recovery benefits have not been established.

TB-500 — illustrative product packagingTB-500TB-500Peptide vials
TB-50010 mg
OMR 19.90 · $52

TB-500 is associated with a fragment of thymosin beta-4. Research examines peptide identity and tissue-related signalling; full-length thymosin findings cannot be assumed for this fragment.

BPC-157 — illustrative product packagingBPC-157BPC-157Peptide vials
BPC-15710 mg
OMR 15.20 · $40

BPC-157 is a 15-amino-acid peptide studied for tissue-repair and gut-related pathways. Most findings come from laboratory and animal models, with limited human evidence.

Illustrative OMR pricing. Product availability and approvals pending confirmation.